Amil, Radzmar G.
HRN: 19-36-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/02/2022
05/09/2022
IV
200mg
Q8
AGE With Mod Dhn
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes